Literature DB >> 1407412

Cerebrospinal fluid endothelin-1 in Alzheimer's disease and senile dementia of Alzheimer type.

T Yoshizawa1, H Iwamoto, H Mizusawa, N Suzuki, H Matsumoto, I Kanazawa.   

Abstract

We have measured the endothelin-1 concentrations in the cerebrospinal fluid samples from 5 patients with Alzheimer's disease (AD), 6 patients with senile dementia of Alzheimer type (SDAT) and 7 patients with other diseases without dementia (disease control: DC). The cerebrospinal fluid endothelin-1 level was significantly lower in AD than in DC. No correlation was observed between cerebrospinal fluid endothelin-1 concentration and any other factors such as age, duration from onset, systolic blood pressure, cerebrospinal fluid protein level or plasma endothelin-1 concentration in AD or SDAT. These results suggest a possible alteration of the endothelin-1 system in the central nervous system in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407412     DOI: 10.1016/0143-4179(92)90059-6

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  3 in total

1.  Cellular distribution of endothelin-1 mRNA in human brain by in situ RT-PCR.

Authors:  V Naidoo; R Mahabeer; D M Raidoo
Journal:  Metab Brain Dis       Date:  2001-12       Impact factor: 3.584

2.  Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides (i).

Authors:  Sigal Fleisher-Berkovich; Talia Filipovich-Rimon; Sarit Ben-Shmuel; Claudia Hülsmann; Markus P Kummer; Michael T Heneka
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

Review 3.  Gene therapy in Alzheimer's disease - potential for disease modification.

Authors:  Per Nilsson; Nobuhisa Iwata; Shin-ichi Muramatsu; Lars O Tjernberg; Bengt Winblad; Takaomi C Saido
Journal:  J Cell Mol Med       Date:  2010-02-16       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.